Gateway to Think Tanks
来源类型 | Working Paper |
规范类型 | 报告 |
DOI | 10.3386/w28162 |
来源ID | Working Paper 28162 |
Why is End-of-Life Spending So High? Evidence from Cancer Patients | |
Dan Zeltzer; Liran Einav; Amy Finkelstein; Tzvi Shir; Salomon M. Stemmer; Ran D. Balicer | |
发表日期 | 2020-12-07 |
出版年 | 2020 |
语种 | 英语 |
摘要 | The concentration of healthcare spending at the end of life is widely documented but poorly understood. To gain insight, we focus on patients newly diagnosed with cancer. They display the familiar pattern: even among cancer patients with similar initial prognoses, monthly spending in the year post diagnosis is over twice as high for those who die within the year than those who survive. This elevated spending on decedents is almost entirely driven by higher inpatient spending, particularly low-intensity admissions, which rise as the prognosis deteriorates. However, even for patients with very poor prognoses at the time of admission, most low-intensity admissions do not result in death, making it difficult to target spending reductions. We also find that among patients with the same cancer type and initial prognosis, end-of-life spending is substantially more elevated for younger patients compared to older patients, suggesting that treatment decisions are not exclusively present-focused. Taken together, these results provide a richer understanding of the sources of high end-of-life spending, without revealing any natural “remedies.” |
主题 | Health, Education, and Welfare ; Health ; Labor Economics ; Demography and Aging |
URL | https://www.nber.org/papers/w28162 |
来源智库 | National Bureau of Economic Research (United States) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/585836 |
推荐引用方式 GB/T 7714 | Dan Zeltzer,Liran Einav,Amy Finkelstein,et al. Why is End-of-Life Spending So High? Evidence from Cancer Patients. 2020. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
w28162.pdf(549KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。